Masliah-Planchon J J

Show results for

Unknown (65)
Transcriptomics (3)
Genomics (3)
Metabolomics (1)
Proteomics (1)

Organisms

Homo sapiens (7)

Repository

biostudies-arrayexpress (3)
EGA (3)
MetaboLights (1)
pride (1)

Tissue

Cell culture (1)

Disease

Breast cancer (1)

Technology Type

OXFORD_NANOPORE, MinION (1)
Mass spectrometry (1)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Q Exactive (1)

Publication Date

2017 (1)
2016 (1)
2010 (1)
2023 (1)
2020 (1)

CHEBI ID

CHEBI:111517 (1)
CHEBI:132188 (1)
CHEBI:132477 (1)
CHEBI:132479 (1)
CHEBI:132546 (1)
CHEBI:132958 (1)
CHEBI:132983 (1)
CHEBI:133028 (1)
CHEBI:133032 (1)
CHEBI:133057 (1)
CHEBI:133077 (1)
CHEBI:133139 (1)
CHEBI:133141 (1)
CHEBI:133144 (1)
CHEBI:133172 (1)
CHEBI:133186 (1)
CHEBI:133223 (1)
CHEBI:133460 (1)
CHEBI:133515 (1)
CHEBI:133559 (1)
CHEBI:133647 (1)
CHEBI:133649 (1)
CHEBI:133672 (1)
CHEBI:133677 (1)
CHEBI:133693 (1)
CHEBI:133733 (1)
CHEBI:137271 (1)
CHEBI:138368 (1)
CHEBI:138529 (1)
CHEBI:141472 (1)

Metabolite Name

(R)-3-hydroxybutyrylcarnitine (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPI (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistamine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-oleoyl-GPI (16:0/18:1)* (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)
1-palmitoyl-2-stearoyl-GPC (16:0/18:0) (1)

Study type

Comparative genomic hybridization by array (1)
Transcription profiling by array (1)
Methylation profiling by array (1)

Release Date

2023 (12)
2024 (11)
2022 (10)
2025 (7)
2021 (6)
2019 (4)
2017 (3)
2016 (3)
2026 (2)
2020 (2)
2018 (2)
2015 (2)
2009 (2)
2010 (1)
2011 (1)

Lab affiliation

Breast Cancer Now The Institute of Cancer Research (1)

Previous page
1 / 8
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 8
Next page

Sort by:

Relevance

Page size

SMARCB1-deficient rhaboid tumors of the kidney and renal medullary carcinomas.

We used microarrays to compared gene expression profilings in various tumors of the kidney. [human mRNA] 8 human RTK, 5 human RMC.

ORGANISM(S): Homo sapiens

2016-03-08 | E-GEOD-70421 | biostudies-arrayexpress

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action.

Not available

S-EPMC5122439 | biostudies-literature

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers

Resistance to endocrine treatments and CDK4/6 inhibitors is considered a near-inevitability in most patients with estrogen receptor positive breast cancers (ER + BC). By genomic and metabolomics analyses of patients' tumours, metastasis-derived patient-derived xenografts (PDX) and isogenic cell line...

2023-06-27 | MTBLS3342 | MetaboLights

Endocarditis due to Neisseria bacilliformis in a patient with a bicuspid aortic valve.

Not available

S-EPMC2691068 | biostudies-literature

Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature.

Not available

S-EPMC11291227 | biostudies-literature

Molecular alterations in high-grade neuroendocrine tumors of the small intestine.

Not available

S-EPMC12805610 | biostudies-literature

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor.

Not available